Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RIFEN - Health Canada Drug Approval Details

Approvals/Health Canada/RIFEN

Authorized

STANDARD

RIFEN

VETVIVA RICHTER GMBH🇨🇦 Health Canada

Approval Date: Apr 6, 2026
Approval ID: f8d254b37de418c6
Company: VETVIVA RICHTER GMBH
Type: Standard

Approval Details

Approval Id: f8d254b37de418c6
Drug Approval Canada Name: RIFEN
Product Name: RIFEN
Status: Marketed
Status Date: 2023-05-18
Original Market Date: 2022-05-24
Drug Class: Veterinary
Dosage Form: Solution
Route Of Administration: Intravenous , Intramuscular
Schedule: PRESCRIPTION
Atc Original: Not Applicable
Aig Number: 0110497002
Company Name: VETVIVA RICHTER GMBH
Company Address: Durisolstrasse 14 Wels -- Austria 4600

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Apr 6, 2026

Approval ID

f8d254b37de418c6

Type

Standard

Back to Health Canada Approvals